Regenerative Medical Technology Group Past Earnings Performance
Past criteria checks 0/6
Regenerative Medical Technology Group's earnings have been declining at an average annual rate of -13%, while the Specialty Retail industry saw earnings growing at 17.1% annually. Revenues have been growing at an average rate of 63% per year.
Key information
-13.0%
Earnings growth rate
-0.9%
EPS growth rate
| Specialty Retail Industry Growth | 26.6% |
| Revenue growth rate | 63.0% |
| Return on equity | n/a |
| Net Margin | -161.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Regenerative Medical Technology Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 3 | -5 | 2 | 0 |
| 30 Jun 24 | 3 | -10 | 2 | 0 |
| 31 Mar 24 | 2 | -10 | 2 | 0 |
| 31 Dec 23 | 2 | -10 | 2 | 0 |
| 30 Sep 23 | 2 | -11 | 2 | 0 |
| 30 Jun 23 | 2 | -6 | 2 | 0 |
| 31 Mar 23 | 2 | -6 | 2 | 0 |
| 31 Dec 22 | 2 | -6 | 2 | 0 |
| 30 Sep 22 | 1 | -6 | 2 | 0 |
| 30 Jun 22 | 1 | -15 | 11 | 0 |
| 31 Mar 22 | 1 | -14 | 10 | 0 |
| 31 Dec 21 | 0 | -13 | 10 | 0 |
| 30 Sep 21 | 0 | -6 | 10 | 0 |
| 30 Jun 21 | 0 | -3 | 1 | 0 |
| 31 Mar 21 | 0 | -6 | 1 | 0 |
| 31 Dec 20 | 0 | -6 | 0 | 0 |
| 30 Sep 20 | 0 | -13 | 2 | 0 |
| 30 Jun 20 | 0 | -7 | 2 | 0 |
| 31 Mar 20 | 0 | -1 | 2 | 0 |
| 31 Dec 19 | 0 | -3 | 2 | 0 |
| 30 Sep 19 | 0 | -3 | 0 | 0 |
| 30 Jun 19 | 0 | -2 | 0 | 0 |
| 31 Mar 19 | 0 | -5 | 0 | 0 |
| 31 Dec 18 | 0 | -2 | 0 | 0 |
| 30 Sep 18 | 0 | -1 | 0 | 0 |
| 31 Dec 17 | 0 | 0 | 0 | 0 |
| 31 Dec 16 | 0 | -4 | 0 | 0 |
| 31 Dec 15 | 0 | -2 | 1 | 0 |
Quality Earnings: RMTG is currently unprofitable.
Growing Profit Margin: RMTG is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RMTG is unprofitable, and losses have increased over the past 5 years at a rate of 13% per year.
Accelerating Growth: Unable to compare RMTG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: RMTG is unprofitable, making it difficult to compare its past year earnings growth to the Specialty Retail industry (-5.9%).
Return on Equity
High ROE: RMTG's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.